PhoenixBioPhoenixBio Co.,Ltd.6190東証グロースサービス業FY ending Mar 2026, consolidated, J-GAAP

PhoenixBio FY ending Mar 2020 results

PhoenixBio brought in ¥1.31B in revenue.

It lost about ¥11 for every ¥100 of sales at the operating level.

Where the money goes

For every ¥100 PhoenixBio sells, how much goes where, and how much is kept.

FY ending Mar 2020

Margin funnel (derived from reported values)Gross margin 66.1% → Operating margin -11.2% → Net margin -31.7%

Show source documents (3)

EDINET (FSA Japan)
有価証券報告書－第23期(2023/04/01－2024/03/31)
ID S100TVPD2024-06-27Open
EDINET (FSA Japan)
有価証券報告書－第21期(令和3年4月1日－令和4年3月31日)
ID S100OKOI2022-06-29Open
EDINET (FSA Japan)
有価証券報告書－第20期(令和2年4月1日－令和3年3月31日)
ID S100LQGW2021-06-25Open

Extracted from XBRL: 38 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.